These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1744976)

  • 1. Impairment of a protective system against atherosclerosis--genetic disorders in HDL metabolism.
    Matsuzawa Y; Sakai N; Yamashita S
    Jpn Circ J; 1991 Oct; 55(10):1010-5. PubMed ID: 1744976
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular mechanisms, lipoprotein abnormalities and atherogenicity of hyperalphalipoproteinemia.
    Yamashita S; Maruyama T; Hirano K; Sakai N; Nakajima N; Matsuzawa Y
    Atherosclerosis; 2000 Oct; 152(2):271-85. PubMed ID: 10998455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hypo- and hyperalphalipoproteinemia and genetic abnormalties in reverse cholesterol transport system].
    Matsuyama A; Yamashita S
    Nihon Rinsho; 2001 Feb; 59 Suppl 2():539-44. PubMed ID: 11351645
    [No Abstract]   [Full Text] [Related]  

  • 4. [Primary hyperalphalipoproteinemia].
    Inazu A; Koizumi J
    Nihon Rinsho; 2001 Mar; 59 Suppl 3():90-3. PubMed ID: 11347189
    [No Abstract]   [Full Text] [Related]  

  • 5. Molecular biology and pathophysiological aspects of plasma cholesteryl ester transfer protein.
    Yamashita S; Hirano K; Sakai N; Matsuzawa Y
    Biochim Biophys Acta; 2000 Dec; 1529(1-3):257-75. PubMed ID: 11111094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CETP and atherosclerosis.
    Barter P
    Arterioscler Thromb Vasc Biol; 2000 Sep; 20(9):2029-31. PubMed ID: 10978244
    [No Abstract]   [Full Text] [Related]  

  • 7. Compound heterozygote of cholesteryl-ester transfer protein deficiency in a patient with hyperalphalipoproteinemia.
    Takegoshi T; Haba T; Kitoh C; Inazu A; Koizumi J; Mabuchi H; Takeda R
    Atherosclerosis; 1992 Sep; 96(1):83-5. PubMed ID: 1418105
    [No Abstract]   [Full Text] [Related]  

  • 8. Genetic mutations affecting human lipoprotein metabolism.
    Zannis VI; Breslow JL
    Adv Hum Genet; 1985; 14():125-215, 383-6. PubMed ID: 2986430
    [No Abstract]   [Full Text] [Related]  

  • 9. [Role of HDL lipoproteins in atherosclerosis].
    Machura B; Kryczka W
    Pol Tyg Lek; 1977 Sep; 32(38):1487-9. PubMed ID: 198755
    [No Abstract]   [Full Text] [Related]  

  • 10. Decreased serum cholesteryl-ester transfer activity in a patient with familial hyper-alpha-lipoproteinemia.
    Takegoshi T; Haba T; Kitoh C; Tokuda T; Mabuchi H
    Clin Chim Acta; 1988 Feb; 171(2-3):343-5. PubMed ID: 3370829
    [No Abstract]   [Full Text] [Related]  

  • 11. High-density lipoproteins and atherosclerosis.
    Betteridge DJ
    Biochem Soc Trans; 1978; 6(5):888-93. PubMed ID: 217757
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cholesterol ester transfer protein (CETP)].
    Bujo H; Saito Y
    Nihon Rinsho; 1990 Nov; 48(11):2492-7. PubMed ID: 2270013
    [No Abstract]   [Full Text] [Related]  

  • 13. Particle size analysis of high density lipoproteins in patients with genetic cholesteryl ester transfer protein deficiency.
    Arai T; Tsukada T; Murase T; Matsumoto K
    Clin Chim Acta; 2000 Nov; 301(1-2):103-17. PubMed ID: 11020466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cholesterol ester transfer protein. A major player in cholesterol metabolism].
    Hansen PR
    Ugeskr Laeger; 1999 Sep; 161(38):5295-8. PubMed ID: 10536513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Very high density lipoproteins induced by plasma cholesteryl ester transfer protein (CETP) have a potent antiatherogenic function.
    Yamashita S; Ishigami M; Arai T; Sakai N; Hirano K; Kameda-Takemura K; Tokunaga K; Matsuzawa Y
    Ann N Y Acad Sci; 1995 Jan; 748():606-8. PubMed ID: 7695214
    [No Abstract]   [Full Text] [Related]  

  • 16. Genetic disorders of high-density lipoprotein metabolism and atherosclerosis--what can we learn?
    Utermann G
    Eur J Clin Invest; 1982 Feb; 12(1):5-7. PubMed ID: 6802652
    [No Abstract]   [Full Text] [Related]  

  • 17. Tangier disease as a test of the reverse cholesterol transport hypothesis.
    Tall AR; Wang N
    J Clin Invest; 2000 Nov; 106(10):1205-7. PubMed ID: 11086021
    [No Abstract]   [Full Text] [Related]  

  • 18. Lipid metabolism.
    Goldberg I
    Curr Opin Lipidol; 1996 Dec; 7(6):U184-92. PubMed ID: 9117132
    [No Abstract]   [Full Text] [Related]  

  • 19. Cholesteryl ester transfer activity in plasma of patients with familial high-density lipoprotein deficiency.
    Sparks DL; Frohlich J; Pritchard PH
    Clin Chem; 1988 Sep; 34(9):1812-5. PubMed ID: 3416429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Remodelling of high density lipoproteins by plasma factors.
    Rye KA; Clay MA; Barter PJ
    Atherosclerosis; 1999 Aug; 145(2):227-38. PubMed ID: 10488948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.